Biomedical Engineering

U.S. NIH selects Vanderbilt University for new molecular screening center

Published in Medical Letter on the CDC and FDA, July 24th, 2005

The U.S. National Institutes for Health announced that Vanderbilt University was one of the centers chosen for the new Molecular Libraries Screening Centers Network (MLSCN), part of the NIH Roadmap Initiative.

"Molecular library screening will give academic researchers the ability to combine high throughput approaches with unique biology to rapidly find small molecule modulators of targets and processes," said Dr. Dave Weaver, director of the Molecular Recognition and Screening Facility at the Vanderbilt Institute of Chemical Biology and a research assistant professor of pharmacology.

"Only in the past few years has high-throughput screening become...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry